WiseGuyReports.com adds “Celecoxib Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2025” reports tits database.

PUNE, MAHARASHTRA, INDIA, March 26, 2019 /EINPresswire.com/ -- Celecoxib Market:

Executive Summary

Global Celecoxib Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Celecoxib Market is continuously growing in global scenario over the coming years. The major driving factor of global Celecoxib market is increasing prevalence of acute pains and musculoskeletal pain in adults. Acute pain and musculoskeletal pain are necessary to treat as they affect the body of humans which results in positive impact in the growth of the market. Moreover, growing demand from end user industries is also a factor which drives the market of celecoxib. The one of the major restraining factor of global celecoxib market is restrictive use of its relative complications. Celecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug. It is used to treat the pain and inflammation of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain in adult, painful menstruation and juvenile rheumatoid arthritis in people two years or older. Celecoxib is available by prescription in capsule form. Celecoxib offers various advantages such as it provides relief in pains, reduce swelling, reduce stiffness & discomfort associated with diseases and safe to use at higher risk for stomach related side effects. The regional analysis of Global Celecoxib Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.

+K19

The major market player included in this report are:

Pfizer
Shire
Teva
Mylan
Chengdu Suncadia Pharmaceutical
Jiangsu Chiatai Qingjiang Pharmaceutical
Anhui Heyi Chemical
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

Request Sample Report @ https://www.wiseguyreports.com/sample-request/3652092-global-celecoxib-market-size-study-by-product-50mg

By Product:

50mg Celecoxib
100mg Celecoxib
200mg Celecoxib
400mg Celecoxib
By End-User/Application:

Rheumatoid Arthritis
Osteoarthritis
Acute Pain
Musculoskeletal Pain
Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025
Target Audience of the Global Celecoxib Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Celecoxib Market, by Product, 2015-2025 (USD Billion)
1.3.2. Celecoxib Market, by End-User/Application, 2015-2025 (USD Billion)
1.3.3. Celecoxib Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Celecoxib Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Celecoxib Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities

Chapter 4. Celecoxib Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion

Chapter 5. Celecoxib Market, by Product
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Celecoxib Market, Sub Segment Analysis
5.4.1. 50mg Celecoxib
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. 100mg Celecoxib
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.3. 200mg Celecoxib
5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.4. 400mg Celecoxib
5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Continuous…

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/3652092-global-celecoxib-market-size-study-by-product-50mg

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.